Programmed Intermittent Epidural Bolus For Laboring Obstetrical Women
- Registration Number
- NCT03712735
- Lead Sponsor
- University of British Columbia
- Brief Summary
Comparison of three programmed intermittent epidural bolus (PIEB) pump settings for maintenance of labour analgesia.
- Detailed Description
The optimal PIEB and patient controlled epidural administered (PCEA) bolus settings are still unknown. Therefore, in this study, the investigators aim to compare analgesia outcomes both high and low PIEB flow rate settings.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 390
Inclusion Criteria
- Singleton, vertex presentations at term (37-42 weeks gestational age)
- </= 5cm cervical dilation at the time of epidural anesthesia request
- ASA 2-3 patients aged 19 or over who are able to provide informed consent
Read More
Exclusion Criteria
- Contraindications to neuraxial analgesia or risk factors likely to affect placement or function of the epidural
- History of hypersensitivity or idiosyncratic reaction to local anesthetics or opioids
- Current or historical evidence of any significant medical conditions
- Clinical settings in which continuous epidural infusion may be preferable
- Risk factors significantly increasing the need for Cesarean delivery
- Anticipated fetal abnormalities
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group C Bupivacaine 0.08% - fentanyl 2mcg Bupivacaine 0.08% - fentanyl 2mcg on the following pump settin PIEB flow rate = low; interval = 45 min Group A Bupivacaine 0.08% - fentanyl 2mcg Bupivacaine 0.08% - fentanyl 2mcg on the following pump settings: PIEB flow rate = high; interval = 60 min Group B Bupivacaine 0.08% - fentanyl 2mcg Bupivacaine 0.08% - fentanyl 2mcg on the following pump settin PIEB flow rate = high; interval = 45 min
- Primary Outcome Measures
Name Time Method Breakthrough pain Duration of labor with epidural Proportion of patients in each group who required a provider administered supplemental bolus for breakthrough pain
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
BC Women's Hospital
🇨🇦Vancouver, British Columbia, Canada